3B Future Health Ventures

3E Bioventures

AAA Family Office

AbbVie

AbbVie Ventures

Acasti Pharma Inc.

Accequa AB

Acelot

Aclipse Therapeutics

Actinogen Medical Ltd.

Acurex Biosciences

Aescuvest International GmbH

age1

AgenT S.A.S.

Albion Ventures LLP

ALCEDIAG

Alexander Shulgin Research Institute

Alfidi Capital

AlgoTx

Allele Capital Partners

Alpha Bronze

ALSA Ventures

Alta Holdings

Andera Partners

Angelini Pharma S.p.a.

Angelini Ventures S.p.A.

Aprecia Pharmaceuticals

Aptar Digital Health

Aqua Partners LLC

ARCH Venture Partners

Argobio Studio

ASDERA LLC

Astellas Venture Management LLC

Astrocyte Pharmaceuticals

atai Life Sciences N.V.

ATEM Capital

Avadel Pharmaceuticals plc

Axoltis Pharma

Bank of America Merrill Lynch

Bio Med Gene Ventures

BioCentury

Biogen

BioHealth Innovation

BIOSTART Consulting GmbH

BioSymetrics

BiotechGate

Biovision Ventures

Bison Ventures

Bloom Science

Boehringer Ingelheim International GmbH

BOHE Angel Fund

BrainTale

Brandon Capital

Breslin AG

Broad Institute of MIT and Harvard

BROTHERS & PARTNERS (MFO)

BTIG

Canaccord Genuity LLC

Cassel Salpeter LLC

CBT Advisors

Centre for Aging + Brain Health Innovation (CABHI)

CereCura Nanotherapeutics

CervoMed Inc.

CIlcare

Clexio Biosciences Ltd.

Cognition Therapeutics

Cohesion Bureau

Coho VC

Compass Pathways

Corundum Neuroscience

CTI Life Sciences Fund

Cukierman & Co. Life Sciences

CuraSen Therapeutics

Cybin Inc.

Daewoong Pharmaceutical Co.

David Fox Syndicate

DCVC Bio

Decheng Capital LLC

Delix Therapeutics

Dementia Discovery Fund - SV Health Investors LLP

Dolby Family Ventures

Dorset Capital LLC

Earlybird Venture Capital

Edison Group

Eight Roads

Eight Roads Ventures

Eikonizo Therapeutics

Eisai Innovation Inc.

Eli Lilly and Company

Feel Therapeutics

Ferghana Partners

Find Therapeutics Inc.

Foothill Ventures

Fortunatus Capital

Frazier Life Sciences

GAIA AG

Gain Therapeutics

Galimedix Therapeutics

Gate Neurosciences

GenEp

Generation Capital

Generation Fund Life Sciences Fund I

GeNeuro SA

GliaPharm SA

Global Alpha Ventures

Global Asset Capital

GLSV GmbH iL

Goetzpartners Securities

GreenSky Capital Inc.

H. Lundbeck A/S

H.C. Wainwright & Co.

HanAll Biopharma

Hankang Capital

Harmonic Pain Solutions

HBM Partners AG

Health Innovation Capital

Healthcare Angels

HEDA Ventures

Hercules Capital

Hestia Investments Ltd.

Hevolution

Hillhouse Capital

Hoba Therapeutics ApS

IAMA Therapeutics S.r.l.

Iaso Ventures

Illumina Ventures

Impact India Investment Partners LLC (3i Partners)

In-Q-Tel

INBRAIN Neuroelectronics

Indaco Venture Partners SGR S.p.A.

Industrifonden

Innovation Works

IPF Partners

Ipsen

Jeito Capital

JLS Fund

Johnson & Johnson Innovation – JJDC

Joyance Partners

JT Pharma

Junson Capital

Kaleida Capital

Keystone Bio

Kynexis Therapeutics

Lactocore Inc.

Ladenburg Thalmann & Co. Inc.

Landmark Family Office/Landmark Angels

LDV Partners

Lifespan Vision Ventures

Lightstone Ventures

Lilly Asia Ventures

LMU Munich

LOFT100 Studios

Longevity Biotech

Lumanity

Lumira Ventures

Lundbeckfonden BioCapital

Lynx Financial Hong Kong Ltd.

Lys Therapeutics

M Ventures

Medicxi

MedinCell S.A.

MedTech Strategist

Medtronic

Medtronic GC Ventures

Mid Atlantic Bio Angels

Minoryx Therapeutics S.L.

Mission BioCapital

Momentum Biotech LLC

Monument Therapeutics Limited

MP Healthcare Venture Management

MRL Venture Funds at Merck

National Institute on Aging

National Institute on Aging (NIA)

Neo Auvra Corp.

NeuCyte

Neuro-Innovators

Neurocentrx Pharma Ltd.

Neuromod Devices

NeuroPn Therapeutics

Neurotech Reports

Neurvati Neurosciences

NeuVasQ Biotechnologies

New Harbor Venture Partners

New Science Fund

New World Strategic Investment Company Limited

Newronika S.p.A.

Nexus NeuroTech Ventures

NI Research Inc.

Nine Square Therapeutics

Noble Capital Markets

Noema Pharma AG

NovaQuest Capital Management LLC

Novo Holdings

Novo Holdings A/S

NRW Venture

NRx Pharmaceuticals

NurrOn Pharmaceuticals Inc.

Ontario Brain Institute

Ontario Teachers’ Pension Plan

Oppenheimer & Co. Inc.

Oryzon Genomics

Otsuka America Pharmaceutical Inc.

Otsuka Holdings Co.

Otsuka Pharmaceuticals Europe Ltd.

Palo Alto Investors

Palo Santo

Panakès Partners SGR SpA

Pangea Bio

Parow Entheobiosciences LLC

PATH Biotech LLC

PharmaVentures Ltd

PigPug Inc.

Pivotal Life Sciences

PJT Partners

Playground Global

Prevail Partners LLC

Pritzker Neuropsychiatric Disorders Research Consortium

Profound Ventures

ProNeurogen

Protobios

Psilera Inc.

PsychoGenics

PsyMed Ventures

Pureos Bioventures

Qiming Venture Partners

Quan Capital

Quince Therapeutics

Raya Therapeutic

Raymond James Financial

Real Endpoints

Relentless Venture Fund

Remiges Ventures

Reunion Neuroscience

Roche

RYSE Asset Management

Samsara BioCapital

Satori Neuro

Sensorium Therapeutics

Seventure Partners

Shanda Group

SIC Venture Studio

Silicon Valley Venture Growth Partners

Sinaptica Therapeutics

Sixty Degree Capital

Sofinnova Investments

Solasta Ventures

Sony Ventures

STALICLA SA

SternAegis Ventures

Stifel

SV Health Investors

Switch Therapeutics

Synendos Therapeutics AG

Tailwinds VC

Tessara Therapeutics Pty Ltd.

The Benchmark Company

The FreeMind Group

The Fulford Group Ltd.

The Michael J. Fox Foundation for Parkinson's Research

Theracast

Theranexus SA

TikoMed AB

Tonix Pharmaceuticals Holding Corp.

Toscana Ventures LLC

TransPacifc Venture Capital Partners

Treo Ventures

TruVenturo GmbH

Two Sigma Ventures

UCB Ventures

UCL Technology Fund

Urry and Rubin Medical Consulting

V-Bio Ventures

Vine Ventures

Vivo Capital

VuEssence

WBB Securities

Wellington Partners

Wilson Hill Ventures

WPSS.bio

WRF Capital

Wyss Center for Bio and Neuroengineering

Xontogeny

Zeto